Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-25 @ 11:30 PM
Study NCT ID:
NCT06456593
Status:
RECRUITING
Last Update Posted:
2025-09-18
First Post:
2024-05-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Sponsor:
Abivax S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-16
First Submit QC Date:
None
Study First Post Date:
2024-06-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-17
Last Update Post Date:
2025-09-18
Last Update Post Date Type:
ESTIMATED